Similar articles for PMID: 17704247

Year	Number of Results
1990	1
1996	1
1998	3
1999	3
2000	11
2001	9
2002	12
2003	21
2004	25
2005	34
2006	40
2007	37
2008	32
2009	18
2010	15
2011	20
2012	16
2013	10
2014	11
2015	13
2016	8
2017	10
2018	3
2019	8
2020	5
2021	4
2022	4
2023	1
2024	0

1

Doxorubicin enhances the expression of transgene under control of the CMV promoter in anaplastic thyroid carcinoma cells.

Kim KI, Kang JH, Chung JK, Lee YJ, Jeong JM, Lee DS, Lee MC. Kim KI, et al. J Nucl Med. 2007 Sep;48(9):1553-61. doi: 10.2967/jnumed.106.038612. Epub 2007 Aug 17. J Nucl Med. 2007. PMID: 17704247 Free article.

2

Cotransfected sodium iodide symporter and human tyroperoxidase genes following human telomerase reverse transcriptase promoter for targeted radioiodine therapy of malignant glioma cells.

Li W, Tan J, Wang P, Wu P. Li W, et al. Cancer Biother Radiopharm. 2011 Aug;26(4):443-51. doi: 10.1089/cbr.2010.0908. Epub 2011 Jul 28. Cancer Biother Radiopharm. 2011. PMID: 21797672

3

Combined RNA interference of hexokinase II and (131)I-sodium iodide symporter gene therapy for anaplastic thyroid carcinoma.

Kim JE, Ahn BC, Hwang MH, Jeon YH, Jeong SY, Lee SW, Lee J. Kim JE, et al. J Nucl Med. 2011 Nov;52(11):1756-63. doi: 10.2967/jnumed.111.090266. Epub 2011 Oct 12. J Nucl Med. 2011. PMID: 21994409 Free article.

4

Combination therapy and noninvasive imaging with a dual therapeutic vector expressing MDR1 short hairpin RNA and a sodium iodide symporter.

Park SY, Kwak W, Thapa N, Jung MY, Nam JO, So IS, Kim SY, Yoo J, Lee J, Kim IS. Park SY, et al. J Nucl Med. 2008 Sep;49(9):1480-8. doi: 10.2967/jnumed.108.050963. Epub 2008 Aug 14. J Nucl Med. 2008. PMID: 18703598 Free article.

5

Radioiodine therapy of colon cancer following tissue-specific sodium iodide symporter gene transfer.

Scholz IV, Cengic N, Baker CH, Harrington KJ, Maletz K, Bergert ER, Vile R, Göke B, Morris JC, Spitzweg C. Scholz IV, et al. Gene Ther. 2005 Feb;12(3):272-80. doi: 10.1038/sj.gt.3302410. Gene Ther. 2005. PMID: 15510175

6

Probasin promoter (ARR(2)PB)-driven, prostate-specific expression of the human sodium iodide symporter (h-NIS) for targeted radioiodine therapy of prostate cancer.

Kakinuma H, Bergert ER, Spitzweg C, Cheville JC, Lieber MM, Morris JC. Kakinuma H, et al. Cancer Res. 2003 Nov 15;63(22):7840-4. Cancer Res. 2003. PMID: 14633711

7

AFP promoter enhancer increased specific expression of the human sodium iodide symporter (hNIS) for targeted radioiodine therapy of hepatocellular carcinoma.

Ma XJ, Huang R, Kuang AR. Ma XJ, et al. Cancer Invest. 2009 Jul;27(6):673-81. doi: 10.1080/07357900802620885. Cancer Invest. 2009. PMID: 19241193

8

Expression of the human sodium/iodide symporter (hNIS) in xenotransplanted human thyroid carcinoma.

Smit JW, Schröder-van der Elst JP, Karperien M, Que I, Romijn JA, van der Heide D. Smit JW, et al. Exp Clin Endocrinol Diabetes. 2001;109(1):52-5. doi: 10.1055/s-2001-11019. Exp Clin Endocrinol Diabetes. 2001. PMID: 11573141

9

Radioiodine therapy of hepatoma using targeted transfer of the human sodium/iodide symporter gene.

Chen L, Altmann A, Mier W, Eskerski H, Leotta K, Guo L, Zhu R, Haberkorn U. Chen L, et al. J Nucl Med. 2006 May;47(5):854-62. J Nucl Med. 2006. PMID: 16644756 Free article.

10

Iodide kinetics and dosimetry in vivo after transfer of the human sodium iodide symporter gene in rat thyroid carcinoma cells.

Haberkorn U, Beuter P, Kübler W, Eskerski H, Eisenhut M, Kinscherf R, Zitzmann S, Strauss LG, Dimitrakopoulou-Strauss A, Altmann A. Haberkorn U, et al. J Nucl Med. 2004 May;45(5):827-33. J Nucl Med. 2004. PMID: 15136633 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

341 results

Results by year